A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation of VX-548

A Randomized, Two-way, Crossover Study to Estimate the Relative Bioavailability of a Controlled-release Formulation of Oxycodone (40 mg) With Sequestered Naltrexone Compared With Immediate-release Oxycodone Tablets (20 mg) in Healthy Volunteers

NCT01677065 ·Status: COMPLETED

Single-Dose, Crossover Study To Compare Bioavailability Of Two Formulations Under Fed And Fasted Conditions

NCT02059915 ·Status: COMPLETED ·Phase: PHASE1

A Study Comparing LTG-001 SDD Formulation To LTG-001 Crystalline Immediate Release Tablets In Healthy Participants

NCT07341152 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Low Back Pain

NCT00449176 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate 90-Day Safety of Tapentadol(CG5503) Immediate Release (IR) or Oxycodone Immediate Release in Patients With Chronic Pain

NCT00364546 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess Bioequivalence of a New Tapentadol Extended-Release Tablet With Respect to a Tapentadol Extended Release Tablet Under Fasted Conditions in Healthy Subjects

NCT02019485 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)

NCT00761150 ·Status: COMPLETED ·Phase: PHASE3

Phase 2 Chronic Low Back Pain Study

NCT01364922 ·Status: COMPLETED ·Phase: PHASE2

Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fasted Conditions

NCT00857428 ·Status: COMPLETED ·Phase: PHASE1

Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fed Conditions

NCT00857142 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic Characterization of Two Novel CG5503 Tablet Formulations in Healthy Volunteers

NCT03956134 ·Status: COMPLETED ·Phase: PHASE1

A Study of Pain Relief in Low Back Pain

NCT00325949 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of CG5503 Prolonged Release (PR) in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee

NCT00486811 ·Status: COMPLETED ·Phase: PHASE3

Transversus Abdominis Plane Block For Renal Transplant Recipients

NCT00905957 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety of Egalet-002 in Patients With Moderate-to-Severe Chronic Low Back Pain

NCT02716857 ·Status: COMPLETED ·Phase: PHASE3

Optimizing Open Label Placebo Rationales

NCT05952960 ·Status: COMPLETED ·Phase: NA

Bioequivalence Study Comparing Naltrexone SR/Bupropion SR Trilayer Tablets From Two Manufacturers

NCT02259179 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine

NCT00505414 ·Status: TERMINATED ·Phase: PHASE3

Oxycodone DETERx™ Versus Placebo in Chronic Low Back Pain (CLBP)

NCT01685684 ·Status: COMPLETED ·Phase: PHASE3

Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain

NCT02603705 ·Status: COMPLETED ·Phase: PHASE3

Bioequivalency Study of Oxymorphone Hydrochloride 10 mg Tablets Under Fasted Conditions

NCT01210638 ·Status: COMPLETED ·Phase: PHASE1

Low-Dose Naltrexone and Acetaminophen Combination in the Treatment of Chronic Low Back Pain (ANODYNE-4)

NCT03201393 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back Pain

NCT01789970 ·Status: COMPLETED ·Phase: PHASE3

Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain

NCT01081912 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and Morphine

NCT00472303 ·Status: COMPLETED ·Phase: PHASE3